AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Hope Bancorp, Inc.

$13.94 +$2.96 (+26.96%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$13.95
Day Range
$13.81$14.14
Year Range
$9.8$14.59
Market Cap
1.78B
AVG Volume
966.08K
Trailing/Forward PE
13.94/9.26
PEG ratio
0.35
Dividend Yield
4.02%
Next Earnings Date
2026-10-27
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q21.02B
26 Q1981.58M
25 Q4967.79M
25 Q3950.73M
25 Q2937.49M
25 Q1964.95M
24 Q41B
24 Q31.04B
24 Q21.07B
24 Q11.11B
Net Income (USD) · TTM
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2127.88M
26 Q166.97M
25 Q458.52M
25 Q348.4M
25 Q241.71M
25 Q194.86M
24 Q499.63M
24 Q3101.77M
24 Q2107.66M
24 Q1120.42M
Operating Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2163.29M
26 Q190.81M
25 Q480.73M
25 Q364.83M
25 Q260.47M
25 Q1124.91M
24 Q4132.96M
24 Q3136.14M
24 Q2144.05M
24 Q1160.98M
EBITDA (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2166.23M
26 Q193.75M
25 Q483.67M
25 Q364.83M
25 Q260.47M
25 Q1124.91M
24 Q4132.96M
24 Q3136.14M
24 Q2144.05M
24 Q1160.98M
Cash Flows (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2183.92M
26 Q1134.82M
25 Q4147.03M
25 Q3125.44M
25 Q2138.41M
25 Q1103.41M
24 Q4106.91M
24 Q3136.09M
24 Q2265.35M
24 Q1415.01M
EPS (USD) · TTM
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q21
26 Q10.52
25 Q40.46
25 Q30.39
25 Q20.35
25 Q10.78
24 Q40.82
24 Q30.84
24 Q20.89
24 Q11
Expenses (USD) · TTM
0100M200M300MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2221.77M
26 Q1202.55M
25 Q4187.37M
25 Q3168.63M
25 Q2203.3M
25 Q1199.18M
24 Q4199.18M
24 Q3208.69M
24 Q2217.55M
24 Q1229.94M
Shares Outstanding (USD) · TTM
-15M-10M-5M05M10MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HOPE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-1.23M
26 Q1-2.24M
25 Q4-7.71M
25 Q3-7.94M
25 Q2-5.88M
25 Q1-5.92M
24 Q4-8.83M
24 Q3-10.03M
24 Q2-11.03M
24 Q1-12.68M
Dividends (USD)
00.511.5May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
HOPE Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.14
May 260.14
Feb 260.14
Nov 250.14
Aug 250.14
May 250.14
Feb 250.14
Nov 240.14
Aug 240.14
May 240.14
Employee Count
05001K1.5K2K2016201720182019202020212022202320242025
HOPE Employee Count by quarter
PeriodEmployee Count
20251.43K
20241.24K
20231.24K
20221.55K
20211.48K
20201.41K
20191.44K
20181.49K
20171.47K
20161.37K
PE Ratio
10203040med 23.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE PE Ratio by quarter
PeriodPE Ratio
Sep 2613.99
Sep 2614.18
Aug 2613.97
Aug 2614.02
Aug 2614.5
Aug 2614.04
Jul 2626.93
Jul 2625.85
Jul 2626.41
Jul 2625.83
Jul 2626.1
Jun 2626.12
Jun 2624.68
Jun 2625.35
Jun 2624.22
May 2624.1
May 2623.79
May 2622.8
May 2623.85
May 2627.7
Apr 2627.35
Apr 2627.57
Apr 2626.95
Apr 2625.59
Mar 2624.03
Mar 2623.85
Mar 2623.76
Mar 2624.51
Feb 2624.78
Feb 2632.31
Feb 2632.26
Feb 2633.24
Jan 2631.83
Jan 2631.2
Jan 2631.09
Jan 2630.74
Jan 2629.18
Dec 2529.89
Dec 2530.42
Dec 2530.61
Dec 2529.04
Nov 2528.22
Nov 2527.5
Nov 2527.34
Nov 2527.79
Oct 2531.4
Oct 2532.12
Oct 2530.62
Oct 2531.4
Oct 2532.27
Sep 2532.57
Sep 2532.75
Sep 2532.75
Sep 2533.29
Aug 2533.32
Aug 2533.05
Aug 2530.83
Aug 2529.81
Aug 2512.43
Jul 2513.33
Jul 2514.58
Jul 2514.72
Jul 2514.8
Jun 2513.83
Jun 2513.01
Jun 2512.97
Jun 2513.1
May 2512.85
May 2512.83
May 2513.47
May 2512.99
May 2512.23
Apr 2512.23
Apr 2511.58
Apr 2511.08
Apr 2511.38
Mar 2512.67
Mar 2512.71
Mar 2512.76
Mar 2512.85
Feb 2513.28
Feb 2512.94
Feb 2513.44
Feb 2513.72
Jan 2513.84
Jan 2514.39
Jan 2514.35
Jan 2513.53
Jan 2514.35
Dec 2414.6
Dec 2414.68
Dec 2415.82
Dec 2415.96
Nov 2416.17
Nov 2416.4
Nov 2416.04
Nov 2416.06
Nov 2413.85
Oct 2413.98
Oct 2414.84
Free Cash Flow Yield
5%10%15%20%med 8.9%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2610.28%
Sep 2610.14%
Aug 2610.3%
Aug 2610.26%
Aug 269.92%
Aug 2610.25%
Jul 267.48%
Jul 267.79%
Jul 267.62%
Jul 267.79%
Jul 267.71%
Jun 267.71%
Jun 268.16%
Jun 267.94%
Jun 268.31%
May 268.35%
May 268.46%
May 268.83%
May 268.44%
May 269.07%
Apr 269.19%
Apr 269.11%
Apr 269.32%
Apr 269.82%
Mar 2610.46%
Mar 2610.53%
Mar 2610.57%
Mar 2610.25%
Feb 2610.14%
Feb 268.02%
Feb 268.04%
Feb 267.8%
Jan 268.14%
Jan 268.31%
Jan 268.34%
Jan 268.43%
Jan 268.88%
Dec 258.67%
Dec 258.52%
Dec 258.47%
Dec 258.92%
Nov 259.19%
Nov 259.42%
Nov 259.48%
Nov 259.33%
Oct 2510.57%
Oct 2510.33%
Oct 2510.84%
Oct 2510.57%
Oct 2510.28%
Sep 2510.19%
Sep 2510.13%
Sep 2510.13%
Sep 259.97%
Aug 259.96%
Aug 2510.04%
Aug 2510.76%
Aug 2511.13%
Aug 258.77%
Jul 258.18%
Jul 257.48%
Jul 257.41%
Jul 257.37%
Jun 257.89%
Jun 258.38%
Jun 258.41%
Jun 258.32%
May 258.48%
May 258.5%
May 258.09%
May 258.39%
May 258.77%
Apr 258.77%
Apr 259.27%
Apr 259.69%
Apr 259.43%
Mar 258.47%
Mar 258.44%
Mar 258.41%
Mar 258.35%
Feb 258.08%
Feb 2510.34%
Feb 259.95%
Feb 259.75%
Jan 259.66%
Jan 259.3%
Jan 259.32%
Jan 259.88%
Jan 259.32%
Dec 249.16%
Dec 249.11%
Dec 248.45%
Dec 248.38%
Nov 248.27%
Nov 248.15%
Nov 248.34%
Nov 248.33%
Nov 2417.79%
Oct 2417.64%
Oct 2416.61%
Price to Sales
11.21.41.61.82med 1.46Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE Price to Sales by quarter
PeriodPrice to Sales
Sep 261.76
Sep 261.78
Aug 261.76
Aug 261.76
Aug 261.82
Aug 261.77
Jul 261.84
Jul 261.76
Jul 261.8
Jul 261.76
Jul 261.78
Jun 261.78
Jun 261.68
Jun 261.73
Jun 261.65
May 261.64
May 261.62
May 261.56
May 261.63
May 261.68
Apr 261.65
Apr 261.67
Apr 261.63
Apr 261.55
Mar 261.45
Mar 261.44
Mar 261.44
Mar 261.48
Feb 261.5
Feb 261.64
Feb 261.64
Feb 261.69
Jan 261.62
Jan 261.59
Jan 261.58
Jan 261.56
Jan 261.49
Dec 251.52
Dec 251.55
Dec 251.56
Dec 251.48
Nov 251.44
Nov 251.4
Nov 251.39
Nov 251.41
Oct 251.4
Oct 251.43
Oct 251.36
Oct 251.4
Oct 251.44
Sep 251.45
Sep 251.46
Sep 251.46
Sep 251.48
Aug 251.48
Aug 251.47
Aug 251.37
Aug 251.33
Aug 251.22
Jul 251.31
Jul 251.43
Jul 251.45
Jul 251.45
Jun 251.36
Jun 251.28
Jun 251.27
Jun 251.29
May 251.26
May 251.26
May 251.32
May 251.28
May 251.22
Apr 251.22
Apr 251.15
Apr 251.1
Apr 251.13
Mar 251.26
Mar 251.27
Mar 251.27
Mar 251.28
Feb 251.32
Feb 251.27
Feb 251.32
Feb 251.35
Jan 251.36
Jan 251.41
Jan 251.41
Jan 251.33
Jan 251.41
Dec 241.43
Dec 241.44
Dec 241.55
Dec 241.57
Nov 241.59
Nov 241.61
Nov 241.57
Nov 241.58
Nov 241.39
Oct 241.4
Oct 241.49
EV/EBITDA
-20-100102030med 9.1Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2610.42
Sep 2610.57
Aug 2610.4
Aug 2610.44
Aug 2610.81
Aug 2610.46
Jul 2617.12
Jul 2616.35
Jul 2616.75
Jul 2616.34
Jul 2616.53
Jun 2616.54
Jun 2615.51
Jun 2615.99
Jun 2615.18
May 2615.1
May 2614.88
May 2614.17
May 2614.92
May 26-7.36
Apr 26-7.61
Apr 26-7.45
Apr 26-7.88
Apr 26-8.84
Mar 26-9.93
Mar 26-10.05
Mar 26-10.11
Mar 26-9.59
Feb 26-9.41
Feb 2620.56
Feb 2620.52
Feb 2621.25
Jan 2620.2
Jan 2619.72
Jan 2619.64
Jan 2619.39
Jan 2618.22
Dec 2518.75
Dec 2519.15
Dec 2519.29
Dec 2518.12
Nov 2517.5
Nov 2516.97
Nov 2516.85
Nov 2517.18
Oct 2513.58
Oct 2514.07
Oct 2513.04
Oct 2513.58
Oct 2514.17
Sep 2514.38
Sep 2514.5
Sep 2514.5
Sep 2514.88
Aug 2514.9
Aug 2514.71
Aug 2513.18
Aug 2512.48
Aug 255.54
Jul 256.22
Jul 257.18
Jul 257.28
Jul 257.34
Jun 256.6
Jun 255.98
Jun 255.95
Jun 256.05
May 255.86
May 255.85
May 256.33
May 255.97
May 258.67
Apr 258.67
Apr 258.18
Apr 257.81
Apr 258.04
Mar 259
Mar 259.03
Mar 259.07
Mar 259.14
Feb 259.46
Feb 25-7.56
Feb 25-7.18
Feb 25-6.97
Jan 25-6.88
Jan 25-6.48
Jan 25-6.5
Jan 25-7.11
Jan 25-6.5
Dec 24-6.32
Dec 24-6.25
Dec 24-5.4
Dec 24-5.29
Nov 24-5.14
Nov 24-4.97
Nov 24-5.24
Nov 24-5.22
Nov 24-5.22
Oct 24-5.12
Oct 24-4.48
Price/Operating Cashflow
468101214med 10.24Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 268.82
Sep 268.94
Aug 268.81
Aug 268.84
Aug 269.15
Aug 268.86
Jul 2611.89
Jul 2611.41
Jul 2611.66
Jul 2611.4
Jul 2611.52
Jun 2611.53
Jun 2610.9
Jun 2611.19
Jun 2610.69
May 2610.64
May 2610.5
May 2610.06
May 2610.53
May 269.85
Apr 269.73
Apr 269.81
Apr 269.59
Apr 269.1
Mar 268.55
Mar 268.48
Mar 268.45
Mar 268.72
Feb 268.81
Feb 2611.38
Feb 2611.36
Feb 2611.71
Jan 2611.21
Jan 2610.99
Jan 2610.95
Jan 2610.83
Jan 2610.27
Dec 2510.53
Dec 2510.71
Dec 2510.78
Dec 2510.23
Nov 259.94
Nov 259.69
Nov 259.63
Nov 259.79
Oct 258.81
Oct 259.01
Oct 258.59
Oct 258.81
Oct 259.05
Sep 259.13
Sep 259.18
Sep 259.18
Sep 259.34
Aug 259.34
Aug 259.27
Aug 258.65
Aug 258.36
Aug 2510.36
Jul 2511.11
Jul 2512.16
Jul 2512.27
Jul 2512.34
Jun 2511.53
Jun 2510.84
Jun 2510.81
Jun 2510.92
May 2510.72
May 2510.69
May 2511.23
May 2510.83
May 2510.44
Apr 2510.44
Apr 259.88
Apr 259.46
Apr 259.72
Mar 2510.82
Mar 2510.85
Mar 2510.89
Mar 2510.97
Feb 2511.34
Feb 259.04
Feb 259.39
Feb 259.59
Jan 259.67
Jan 2510.05
Jan 2510.03
Jan 259.46
Jan 2510.03
Dec 2410.2
Dec 2410.26
Dec 2411.06
Dec 2411.16
Nov 2411.3
Nov 2411.46
Nov 2411.21
Nov 2411.22
Nov 245.42
Oct 245.46
Oct 245.8
Price to Book
0.50.60.70.80.9med 0.65Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HOPE Price to Book by quarter
PeriodPrice to Book
Sep 260.78
Sep 260.79
Aug 260.78
Aug 260.78
Aug 260.81
Aug 260.78
Jul 260.79
Jul 260.76
Jul 260.77
Jul 260.76
Jul 260.77
Jun 260.77
Jun 260.72
Jun 260.74
Jun 260.71
May 260.71
May 260.7
May 260.67
May 260.7
May 260.71
Apr 260.7
Apr 260.71
Apr 260.69
Apr 260.66
Mar 260.62
Mar 260.61
Mar 260.61
Mar 260.63
Feb 260.64
Feb 260.69
Feb 260.69
Feb 260.71
Jan 260.68
Jan 260.67
Jan 260.67
Jan 260.66
Jan 260.63
Dec 250.64
Dec 250.65
Dec 250.66
Dec 250.62
Nov 250.61
Nov 250.59
Nov 250.59
Nov 250.6
Oct 250.59
Oct 250.6
Oct 250.57
Oct 250.59
Oct 250.61
Sep 250.61
Sep 250.61
Sep 250.61
Sep 250.62
Aug 250.62
Aug 250.62
Aug 250.58
Aug 250.56
Aug 250.55
Jul 250.59
Jul 250.64
Jul 250.65
Jul 250.65
Jun 250.61
Jun 250.57
Jun 250.57
Jun 250.58
May 250.56
May 250.56
May 250.59
May 250.57
May 250.57
Apr 250.57
Apr 250.54
Apr 250.52
Apr 250.53
Mar 250.59
Mar 250.59
Mar 250.6
Mar 250.6
Feb 250.62
Feb 250.61
Feb 250.63
Feb 250.64
Jan 250.65
Jan 250.67
Jan 250.67
Jan 250.63
Jan 250.67
Dec 240.68
Dec 240.69
Dec 240.74
Dec 240.75
Nov 240.76
Nov 240.77
Nov 240.75
Nov 240.75
Nov 240.71
Oct 240.71
Oct 240.76
Hope Bancorp, Inc.
HOPE
Stockpicker

Video analysis: HOPE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HOPE

Bank of Hope Receives Regulatory Approvals to Acquire the Commercial Banking Unit of SMBC MANUBANK

businesswire.com · 2 Sep 2026

Bank of Hope Receives Regulatory Approvals to Acquire the Commercial Banking Unit of SMBC MANUBANK

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that its wholly-owned subsidiary, Bank of Hope, has received all regulatory approvals required to complete the previously announced acquisition of the Commercial Banking Unit of SMBC MANUBANK (“MANUBANK”), a wholly owned subsidiary of SMBC Americas Holdings, Inc. and Sumitomo Mitsui Banking Corporation (“SMBC”). Regulatory approvals have been received from the Federal Deposit Insurance Corporation and the California.

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

gurufocus.com · 6 Aug 2026

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂ platform to develop in vivo gene editi

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics' Deramiocel in Duchenne Muscular Dystrophy

globenewswire.com · 29 Jul 2026

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics' Deramiocel in Duchenne Muscular Dystrophy

--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with Deramiocel Slowing Upper Limb Function Decline by 54 Percent versus Placebo (PUL 2.0, p=0.03) and Showing Clinically Meaningful Cardiac Benefit--

Hope Bancorp's Great Quarter Doesn't Mean An Upgrade Is Justified

seekingalpha.com · 28 Jul 2026

Hope Bancorp's Great Quarter Doesn't Mean An Upgrade Is Justified

Hope Bancorp delivered a strong Q2 2026, with revenue and adjusted EPS both exceeding analyst expectations and a swing from loss to profit. HOPE's net interest margin expanded to 2.96%, deposits and loans grew, and non-interest income rebounded sharply due to the absence of prior-year securities losses. Despite trading below book value, HOPE's forward P/E of 13.8 and subpar asset quality (ROA 0.71%, ROE 5.76%) limit its attractiveness.

Bank of Hope Launches K-pop Culture Inspired Campaign Encompassing Sponsorship to Increase Brand Visibility, Strengthen Customer Connections

businesswire.com · 28 Jul 2026

Bank of Hope Launches K-pop Culture Inspired Campaign Encompassing Sponsorship to Increase Brand Visibility, Strengthen Customer Connections

NEW YORK--(BUSINESS WIRE)--Bank of Hope, subsidiary of Hope Bancorp, Inc. (NASDAQ: HOPE), is expanding the ways it connects with customers and community members through a creative branding campaign centered on a sponsorship of 'BTS THE CITY ARIRANG NEW YORK'. Celebrating ‘BTS THE CITY ARIRANG NEW YORK' as people from around the world gather in New York City, this campaign serves as a unique activation targeted at today's consumers who seek meaningful relationships with the brands with which the.

Hope Bancorp, Inc. (HOPE) Q2 2026 Earnings Call Transcript

seekingalpha.com · 27 Jul 2026

Hope Bancorp, Inc. (HOPE) Q2 2026 Earnings Call Transcript

Hope Bancorp, Inc. (HOPE) Q2 2026 Earnings Call Transcript

Hope Bancorp Q2 Earnings Call Highlights

marketbeat.com · 27 Jul 2026

Hope Bancorp Q2 Earnings Call Highlights

Hope Bancorp NASDAQ: HOPE reported higher second-quarter earnings and revenue as net interest margin expanded, loan growth accelerated and the company continued to improve its deposit mix ahead of its planned acquisition of SMBC MANUBANK's commercial banking unit.

Hope Bancorp (HOPE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

zacks.com · 27 Jul 2026

Hope Bancorp (HOPE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Hope Bancorp (HOPE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.